Since the 1990s, it has also been known that a specific signalling protein, the cytokine Interleukin-5 (IL-5), is essential for eosinophilia. This led to the development and market introduction of ...

Since the 1990s, it has also been known that a specific signalling protein, the cytokine Interleukin-5 (IL-5), is essential for eosinophilia. This led to the development and market introduction of ...

Eosinophils are a type of white blood cell. Low eosinophil numbers may occur due to certain medications or an underlying health condition, such as Cushing syndrome. Eosinophils play a role in the ...

Since the 1990s, it has also been known that a specific signaling protein, the cytokine Interleukin-5 (IL-5), is essential for eosinophilia. This has led to the development and market introduction ...

the lobar distribution and the presence of pulmonary infiltrations before the development of blood eosinophilia. Moreover, tests for infection with trichinae and echinococci were negative.

a lot of our patients have elevated eosinophils for other reasons, like allergic asthma or allergic diseases,” he said. “That might put them at higher risk for development of these ...

Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with ...

Capitalizing on knowledge regarding eosinophil cell biology has led to a remarkable increase in the development of eosinophil-specific therapies.” Treatments targeting eosinophils have been ...

First identified in 1989, eosinophilia-myalgia syndrome is a rare condition that produces inflammation in the muscles, lungs, ...

The FDA approved dupilumab for eosinophilic esophagitis in children ... failure to thrive at a critical time of their growth and development.” In January, the FDA approved dupilumab (Dupixent ...